Xencor | Nettoeinkommen



Net Income Veränderung Datum
AbbVie USD -22000000 1.58B 2024-12
Alnylam Pharmaceuticals USD -83763000 27.81M 2024-12
Amgen USD 627M 2.2B 2024-12
Arrowhead Research USD -173085000 2.55M 2024-12
AstraZeneca USD 1.5B 71M 2024-12
Biogen USD 266.7M 121.8M 2024-12
Bristol-Myers Squibb USD 72M 1.14B 2024-12
Cytokinetics USD -150020000 10.52M 2024-12
GlaxoSmithKline GBP 414M 472M 2024-12
J&J USD 3.43B 737M 2024-12
MacroGenics USD 56.31M 111.97M 2024-09
Merck USD 3.74B 586M 2024-12
Novartis USD 2.82B 371M 2024-12
Pfizer USD 410M 4.06B 2024-12
Regeneron Pharmaceuticals USD 917.7M 422.9M 2024-12
Roche Holding CHF 1.01B 2.12B 2024-12
Xencor USD -53479000 8.34M 2024-12



Xencor Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.